Normalizing effects of gamma-linolenic acid on etretinate-induced hypertriglyceridemia in psoriatic patients: Preliminary results

G. Vignati, C. Zaccone, G. Vignoli, G. Rabbiosi, G. Borroni

Research output: Contribution to journalArticle

Abstract

Retinoids are a group of synthesis compounds having vitamin A as their precursor. Among retinoids, etretinate is commonly used, alone or in combination with PUVA (8-methoxypsoralen + UVA), for diffuse and resistant psoriasis. However eretrinate may induce local (severe skin dryness, flaking, cheilitis and fissures) and systemic side-effects. Among the systemic side-effects of etretinate, increased triglycerides, VLDLs, and cholesterol are frequently detected, which may cause treatment discontinuation. In the present paper 41 psoriatic patients undergoing Re-PUVA (Etretinate + PUVA) were considered. One month after the beginning of the therapy, 27 of them were additionally treated with gamma-linolenic acid, because of the dryness and itch induced by etretinate. During Re-PUVA treatment 11 out of these 27 patients showed increased triglyceride and cholesterol levels. A 2 month-treatment with gamma-linolenic acid induced an improvement of the cutaneous side-effects of etretinate. Moreover, a statistically significant decrease of triglyceridemia (p <0.01) and cholesterolemia (p <0.01) was detected following the treatment with gamma-linolenic acid. These results demonstrate that association of gamma-linolenic acid is useful in controlling dyslipidemia if Re-PUVA treatment has to be continued to achieve clearing of psoriasis.

Original languageEnglish
Pages (from-to)107-112
Number of pages6
JournalJournal of Applied Cosmetology
Volume11
Issue number4
Publication statusPublished - 1993

Fingerprint

gamma-Linolenic Acid
Etretinate
Hypertriglyceridemia
Methoxsalen
Retinoids
Psoriasis
Therapeutics
Cheilitis
VLDL Cholesterol
Skin
Dyslipidemias
Vitamin A
Triglycerides
Cholesterol

Keywords

  • etretinate
  • gamma-linolenic acid
  • hypertriglyceridemia
  • psoriasis

ASJC Scopus subject areas

  • Dermatology

Cite this

Normalizing effects of gamma-linolenic acid on etretinate-induced hypertriglyceridemia in psoriatic patients : Preliminary results. / Vignati, G.; Zaccone, C.; Vignoli, G.; Rabbiosi, G.; Borroni, G.

In: Journal of Applied Cosmetology, Vol. 11, No. 4, 1993, p. 107-112.

Research output: Contribution to journalArticle

Vignati, G. ; Zaccone, C. ; Vignoli, G. ; Rabbiosi, G. ; Borroni, G. / Normalizing effects of gamma-linolenic acid on etretinate-induced hypertriglyceridemia in psoriatic patients : Preliminary results. In: Journal of Applied Cosmetology. 1993 ; Vol. 11, No. 4. pp. 107-112.
@article{dff208f474314bd3ab75c6e01cd5a4e7,
title = "Normalizing effects of gamma-linolenic acid on etretinate-induced hypertriglyceridemia in psoriatic patients: Preliminary results",
abstract = "Retinoids are a group of synthesis compounds having vitamin A as their precursor. Among retinoids, etretinate is commonly used, alone or in combination with PUVA (8-methoxypsoralen + UVA), for diffuse and resistant psoriasis. However eretrinate may induce local (severe skin dryness, flaking, cheilitis and fissures) and systemic side-effects. Among the systemic side-effects of etretinate, increased triglycerides, VLDLs, and cholesterol are frequently detected, which may cause treatment discontinuation. In the present paper 41 psoriatic patients undergoing Re-PUVA (Etretinate + PUVA) were considered. One month after the beginning of the therapy, 27 of them were additionally treated with gamma-linolenic acid, because of the dryness and itch induced by etretinate. During Re-PUVA treatment 11 out of these 27 patients showed increased triglyceride and cholesterol levels. A 2 month-treatment with gamma-linolenic acid induced an improvement of the cutaneous side-effects of etretinate. Moreover, a statistically significant decrease of triglyceridemia (p <0.01) and cholesterolemia (p <0.01) was detected following the treatment with gamma-linolenic acid. These results demonstrate that association of gamma-linolenic acid is useful in controlling dyslipidemia if Re-PUVA treatment has to be continued to achieve clearing of psoriasis.",
keywords = "etretinate, gamma-linolenic acid, hypertriglyceridemia, psoriasis",
author = "G. Vignati and C. Zaccone and G. Vignoli and G. Rabbiosi and G. Borroni",
year = "1993",
language = "English",
volume = "11",
pages = "107--112",
journal = "Journal of Applied Cosmetology",
issn = "0392-8543",
publisher = "International Ediemme",
number = "4",

}

TY - JOUR

T1 - Normalizing effects of gamma-linolenic acid on etretinate-induced hypertriglyceridemia in psoriatic patients

T2 - Preliminary results

AU - Vignati, G.

AU - Zaccone, C.

AU - Vignoli, G.

AU - Rabbiosi, G.

AU - Borroni, G.

PY - 1993

Y1 - 1993

N2 - Retinoids are a group of synthesis compounds having vitamin A as their precursor. Among retinoids, etretinate is commonly used, alone or in combination with PUVA (8-methoxypsoralen + UVA), for diffuse and resistant psoriasis. However eretrinate may induce local (severe skin dryness, flaking, cheilitis and fissures) and systemic side-effects. Among the systemic side-effects of etretinate, increased triglycerides, VLDLs, and cholesterol are frequently detected, which may cause treatment discontinuation. In the present paper 41 psoriatic patients undergoing Re-PUVA (Etretinate + PUVA) were considered. One month after the beginning of the therapy, 27 of them were additionally treated with gamma-linolenic acid, because of the dryness and itch induced by etretinate. During Re-PUVA treatment 11 out of these 27 patients showed increased triglyceride and cholesterol levels. A 2 month-treatment with gamma-linolenic acid induced an improvement of the cutaneous side-effects of etretinate. Moreover, a statistically significant decrease of triglyceridemia (p <0.01) and cholesterolemia (p <0.01) was detected following the treatment with gamma-linolenic acid. These results demonstrate that association of gamma-linolenic acid is useful in controlling dyslipidemia if Re-PUVA treatment has to be continued to achieve clearing of psoriasis.

AB - Retinoids are a group of synthesis compounds having vitamin A as their precursor. Among retinoids, etretinate is commonly used, alone or in combination with PUVA (8-methoxypsoralen + UVA), for diffuse and resistant psoriasis. However eretrinate may induce local (severe skin dryness, flaking, cheilitis and fissures) and systemic side-effects. Among the systemic side-effects of etretinate, increased triglycerides, VLDLs, and cholesterol are frequently detected, which may cause treatment discontinuation. In the present paper 41 psoriatic patients undergoing Re-PUVA (Etretinate + PUVA) were considered. One month after the beginning of the therapy, 27 of them were additionally treated with gamma-linolenic acid, because of the dryness and itch induced by etretinate. During Re-PUVA treatment 11 out of these 27 patients showed increased triglyceride and cholesterol levels. A 2 month-treatment with gamma-linolenic acid induced an improvement of the cutaneous side-effects of etretinate. Moreover, a statistically significant decrease of triglyceridemia (p <0.01) and cholesterolemia (p <0.01) was detected following the treatment with gamma-linolenic acid. These results demonstrate that association of gamma-linolenic acid is useful in controlling dyslipidemia if Re-PUVA treatment has to be continued to achieve clearing of psoriasis.

KW - etretinate

KW - gamma-linolenic acid

KW - hypertriglyceridemia

KW - psoriasis

UR - http://www.scopus.com/inward/record.url?scp=0027858945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027858945&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0027858945

VL - 11

SP - 107

EP - 112

JO - Journal of Applied Cosmetology

JF - Journal of Applied Cosmetology

SN - 0392-8543

IS - 4

ER -